Menu
Back to Journals » Clinical Ophthalmology » Volume 14
Comparative AAPOS Validation of the blinq. Birefringent Amblyopia Screener with Isolated Small-Angle Strabismus [Response to Letter]
Authors Arnold RW
Received 19 August 2020
Accepted for publication 19 August 2020
Published 23 September 2020 Volume 2020:14 Pages 2775—2776
Robert W Arnold
Pediatric Ophthalmology and Strabismus, Alaska Children’s EYE & Strabismus, Anchorage, Alaska 99508, USA
Correspondence: Robert W Arnold
Pediatric Ophthalmology and Strabismus, Alaska Children’s EYE & Strabismus, 3500 Latouche #280, Anchorage, Alaska 99508, USA
Tel +1 (907)561-1917
Fax +1 (907)563-5373
Email eyedoc@alaska.net
Since I was first introduced to the amazing concept of bilateral birefringent screening championed by David G Hunter and David Guyton decades ago, I have been longing to try the technology on my patients so I purchased the blinq.™ device as soon as it became commercially available in late 2019.
View the original paper by Arnold
This is in response to the Letter to the Editor
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.